Cytogenetic and molecular testing have become increasingly important in the diagnosis and classification and include identifying predisposing somatic mutations and karyotype abnormalities and revealing a distinct mutational landscape of childhood MDS involving somatic mutations in SETBP1, ASXL1, RUNX1, and the RAS pathway [5,11]. The gene discussed is SETBP1; the disease is myelodysplastic syndrome.